Copper Hepatopathy in Dogs: How a Deleted Regulation Created a Liver Disease

First, what copper actually does in your dog

Copper is not optional. Your dog needs it to make red blood cells, build connective tissue, produce melanin and certain neurotransmitters, and run one of the body's most important antioxidant enzymes (Cu/Zn superoxide dismutase). Take copper out of the diet entirely and the dog gets anemic, depigmented, and weak.

But copper is also one of the narrowest therapeutic margins in canine nutrition. The body only needs trace amounts. Anything beyond what's used gets stored in the liver. The liver has limited capacity to excrete it. Once storage exceeds capacity, the excess starts damaging hepatocytes. The damage is silent for months or years. By the time symptoms appear (vomiting, jaundice, weight loss, ascites), the liver is already in trouble.

This is why every regulatory body that has thought carefully about copper has set both a minimum and a maximum. The European Food Safety Authority sets a maximum tolerable dietary copper level for dogs. The National Research Council's 2006 nutrient requirements monograph listed copper as a nutrient with a Safe Upper Limit category, then declined to assign a specific number due to insufficient data, a gap they explicitly flagged for future revision.

Two regulatory bodies set a ceiling. The third deleted theirs.

2007: AAFCO deletes the copper maximum

For a decade, AAFCO's Dog Food Nutrient Profiles included both a minimum and a maximum for copper. The maximum sat at 250 mg per kilogram of dry matter for adult maintenance. It was not aggressive, but it was a ceiling.

In 2007, the AAFCO Canine Nutrition Expert Subcommittee (CNES) revised the profiles. The revision deleted the copper maximum entirely. The stated rationale, summarized in the proceedings, was that copper deficiency was a more frequently documented problem than copper excess, and that a numerical maximum was not warranted given available data.

This reasoning had a problem. The "available data" on copper excess was almost entirely from Bedlington Terriers, the canonical genetic predisposition case. Other breed signals (Labradors, Dobermans, Westies) were starting to appear in the veterinary literature but had not yet accumulated into a clear population-level pattern. AAFCO's structure is worth understanding here: the panel that writes the rules is drawn heavily from industry nutritionists, the deliberations are not public in the way FDA dockets are, and there is no formal precautionary requirement built into the process. A maximum can be deleted because the available evidence has not yet crystallized into a clean reason to keep it.

A deleted ceiling is not the same as an explicit license to add unlimited copper. But in practice, with no regulatory upper bound and a marketing incentive toward higher micronutrient panels ("more enriched"), the industry-wide drift has been upward.

The breeds that cannot process copper normally

Copper hepatopathy is not a single disease. It is a category of liver disease where copper accumulates beyond the liver's capacity to excrete it. The cause can be a clean genetic defect, a population-level susceptibility, or, most controversially, dietary exposure alone in a dog with no known predisposition. The breeds break down roughly into three tiers.

The remaining 150-plus breeds and mixed breeds have lower baseline susceptibility, but lower is not zero. Case reports of copper hepatopathy in mixed breeds and in breeds with no previously documented signal have accumulated steadily since the early 2010s.

When the cases started showing up in breeds with no genetic excuse

For decades, the standard veterinary teaching on copper hepatopathy was: Bedlingtons get it because of a known mutation. Some Labradors get it. Everyone else gets idiopathic chronic hepatitis from causes we cannot pin down. The disease was on the curriculum, but the dietary angle was a footnote.

Beginning in the early 2010s, internists started noticing something different. Cases of chronic hepatitis in non-predisposed breeds were coming in with hepatic copper quantifications above the upper reference range. The dogs were not on supplemental copper. They were not exposed to industrial sources. They were eating commercial kibble.

When those dogs were biopsied, the histology often showed copper accumulation. When they were put on copper-restricted diets and chelation therapy, the liver enzymes normalized and the cases resolved. This was happening across multiple referral hospitals independently, with veterinary internists publishing case series and observational reports that converged on the same pattern.

The 2019 ACVIM consensus statement on chronic hepatitis in dogs (Webster et al., J Vet Intern Med, PMID 30844094) formalized this shift. The consensus statement named "copper-associated chronic hepatitis" as a distinct diagnostic category, listed copper measurement on biopsy as part of the standard workup, and acknowledged that nutritional copper exposure may contribute to cases outside the historically predisposed breeds.

This was a quiet but important moment. The category was no longer fringe. It was in the consensus document.

Center 2021: a senior academic formally calls for action

In March 2021, the Journal of the American Veterinary Medical Association published a commentary titled "Is it time to reconsider current guidelines for copper content in commercial dog foods?" The lead author was Dr. Sharon A. Center, professor at Cornell University and one of the most experienced hepatologists in veterinary medicine. The co-authors were a combined faculty list from Cornell, Colorado State, Texas A&M, and Tufts.

The paper laid out a specific argument. Over the preceding fifteen years, the authors had documented an increasing frequency of severe copper-associated chronic hepatitis in dogs with no known genetic predisposition. They reviewed the timeline of regulatory and industry changes that overlapped with this rise: the 2007 AAFCO deletion of the copper maximum, the industry shift toward chelated copper supplements, the upward drift in copper content in commercial formulations.

They then made a formal recommendation. AAFCO should reconsider the deletion. A maximum should be reinstated. The minimum should be re-examined in light of bioavailability data. Pet food companies should be encouraged to test finished product copper content and balance copper with zinc rather than maximize copper alone.

AAFCO has not yet revisited the maximum. The CNES has acknowledged the concern in subsequent proceedings and discussed possible revisions, but as of the 2024 Official Publication, no maximum has been reinstated.

Chelation, or why "how much" is not the only question

The total milligrams of copper in a kilogram of dog food is one number. How much of that copper actually enters the dog's bloodstream is a different number. The gap between them is where bioavailability lives, and bioavailability is where the chelation story sits.

Until roughly 2005, most commercial dog foods used inorganic copper sources: copper sulfate and copper oxide. Copper sulfate is moderately bioavailable. Copper oxide is poorly absorbed and was largely phased out for that reason. The numerical copper content of a kibble in 1998 overstated the copper a dog actually absorbed.

Beginning in the early 2000s, the industry shifted toward chelated copper: copper proteinate, copper amino acid chelate, copper glycinate. Chelated forms bind the copper to an organic carrier (an amino acid or short peptide) that the intestine recognizes as a protein-bound nutrient rather than a free mineral. This dramatically increases absorption. Independent estimates put chelated copper bioavailability at roughly 3 to 4 times that of copper sulfate.

Chelated minerals are not inherently bad. For nutrients with a wide therapeutic margin (manganese, iron in most contexts), the higher bioavailability is purely beneficial. For copper specifically, where the margin is narrow and the failure mode is silent hepatic accumulation, the same upgrade quietly raises the practical dose. AAFCO's deletion of the maximum happened the same decade chelated copper supplements became the industry default. These two changes compounded.

Reading a dog food label, the way to spot this is the supplement panel near the bottom of the ingredient list. "Copper sulfate" is one disclosure. "Copper proteinate" or "copper amino acid chelate" is a different disclosure. Sniff parses these forms and flags chelated copper without balancing zinc on every product page.

The zinc-copper balance nobody is checking

Zinc and copper compete for absorption at the intestinal lining. They use overlapping transport proteins. Increasing dietary zinc reduces copper absorption. Decreasing zinc increases it. This is well-established physiology in both human and animal nutrition.

Clinically, this is so well-known that one of the standard treatments for copper accumulation in both dogs and humans is supplemental zinc, specifically to block intestinal copper uptake.

Commercial dog foods include both zinc and copper in their micronutrient panels. The AAFCO minimums for both are set independently of each other. There is no required ratio. Some formulations end up with a zinc-to-copper ratio of 10 to 1 or higher (closer to the physiologically balanced range). Others land below 5 to 1, which shifts the absorption balance toward copper.

Most dog food companies do not publish their zinc-to-copper ratios. They are not required to. The ratio matters more for predisposed breeds than for general populations, but it matters everywhere as a structural design parameter that almost no one is checking.

Copper-restricted diets work, which is the cleanest evidence we have

The strongest piece of evidence that the dietary connection is real is also the simplest: when dogs diagnosed with copper-associated chronic hepatitis are put on copper-restricted diets, their liver enzymes normalize. Not always, but often. The relationship is consistent enough that the ACVIM consensus statement specifies dietary copper restriction as a first-line treatment alongside chelation therapy.

This is a different kind of evidence than a population-level dose-response study, which would be the gold standard but has not been done. It is the kind of evidence that medicine usually treats as causal: remove the suspected exposure, watch the outcome reverse, conclude the exposure was contributing.

If commercial dog food copper content were entirely irrelevant to the chronic hepatitis seen in non-predisposed breeds, copper restriction would not work as reliably as it does.

What Sniff does about it

Sniff's rubric treats copper as a Controversial Ingredient Penalty (CIP) condition, not a hard FLAG. Here is what that means in practice, and why it is set that way.

What we do not know (and what we will do when we find out)

This is an unfinished story. Here is what remains genuinely uncertain.

If a population dose-response trial publishes results that exonerate dietary copper at commercial levels, we will lift the WATCH flag and update the rubric. If the trial confirms a clear toxic threshold, we will tighten to FLAG. Either way, the change will land in a public versioned rubric update with a changelog that explains what shifted and why.

Where Sniff stands

We apply the Lindy principle here too. Copper at levels matching the historic NRC Recommended Allowance, in inorganic form, has been part of the canine commercial diet for decades without a documented signal. Chelated copper supplements at industry-default loadings, with no balancing zinc, in a regulatory environment with no maximum, have a roughly fifteen-year track record. The case literature has not been silent during those fifteen years.

We do not panic. We do not stay silent.

WATCH is the right posture for evidence that is strong in the clinical literature but not yet settled in the population literature. WATCH means we tell you the concern exists, we explain what triggered the flag, and we let you weigh it against the rest of the product's formulation.

We publish everything. The rubric component that handles copper is named, weighted, and documented on the methodology page. If you think the WATCH is too aggressive, you can read exactly which line of the rubric triggered it. If you think it is not aggressive enough, you can say so on the corrections page. If new evidence comes in, the rubric updates and the score updates with it.

We are precautionary, not alarmist. A WATCH flag on a chelated-copper-without-balancing-zinc product is not "this food is poisoning your dog." It is "the regulator deleted a ceiling the same decade the industry doubled the bioavailability of this micronutrient, the clinical literature is documenting a pattern, and the predisposed breeds are showing up more often than expected. You should know."

Frequently asked questions

Related reading